Diagnostics

Distribution by Scientific Domains
Distribution within Medical Sciences

Kinds of Diagnostics

  • cancer diagnostics
  • clinical diagnostics
  • influence diagnostics
  • medical diagnostics
  • molecular diagnostics
  • routine diagnostics


  • Selected Abstracts


    REAL-TIME EXPERIMENTAL INVESTIGATION OF DYNAMIC CRACK BRANCHING USING HIGH-SPEED OPTICAL DIAGNOSTICS

    EXPERIMENTAL TECHNIQUES, Issue 2 2003
    L.R. Xu
    First page of article [source]


    DIAGNOSTICS AND IMAGING PROCEDURES

    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, Issue 2006
    Article first published online: 6 JUL 200
    No abstract is available for this article. [source]


    DIAGNOSTICS AND IMAGING PROCEDURES

    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, Issue 2006
    Article first published online: 6 JUL 200
    First page of article [source]


    Tumor imaging in small animals with a combined micro-CT/micro-DSA system using iodinated conventional and blood pool contrast agents

    CONTRAST MEDIA & MOLECULAR IMAGING, Issue 4 2006
    Cristian T. Badea
    Abstract X-ray based micro-computed tomography (CT) and micro-digital subtraction angiography (DSA) are important non-invasive imaging modalities for following tumorogenesis in small animals. To exploit these imaging capabilities further, the two modalities were combined into a single system to provide both morphological and functional data from the same tumor in a single imaging session. The system is described and examples are given of imaging implanted fibrosarcoma tumors in rats using two types of contrast media: (a) a new generation of blood pool contrast agent containing iodine with a concentration of 130,mg/mL (FenestraÔ VC, Alerion Biomedical, San Diego, CA, USA) for micro-CT and (b) a conventional iodinated contrast agent (Isovue®-370,mg/mL iodine, trademark of Bracco Diagnostics, Princeton, NJ, USA) for micro-DSA. With the blood pool contrast agent, the 3D vascular architecture is revealed in exquisite detail at 100,µm resolution. Micro-DSA images, in perfect registration with the 3D micro-CT datasets, provide complementary functional information such as mean transit times and relative blood flow through the tumor. This imaging approach could be used to understand tumor angiogenesis better and be the basis for evaluating anti-angiogenic therapies. Copyright © 2006 John Wiley & Sons Ltd. [source]


    Spectroscopic Diagnostics of Pulsed arc Plasmas for Particle Generation

    CONTRIBUTIONS TO PLASMA PHYSICS, Issue 8 2008
    K. Behringer
    Abstract Pulsed arc plasmas were diagnosed by means of emission spectroscopy. A capacitor was discharged through argon and hydrogen leading to a few cycles of damped current oscillation with ,120 ,s period and 5-12 kA maximum current. Spectroscopic measurements in the visible range were carried out in order to characterise the electron temperature and density in the arc channel as well as electron and gas temperatures in the afterglow plasmas. Spectra were integrated over 10 ,s time windows and shifted in time from pulse to pulse. The plasmas also contained substantial fractions of electrode material (brass), namely copper and zinc. The electron density was measured in the conventional way from the broadening of H, or from the Ar I Stark width. In the arc channel, it ranged from about 3 · 1022 to 2 · 1023 m,3. The broadening of Zn II lines could also be used. Ratios of Ar I to Ar II and of Zn I to Zn II line intensities were analysed for the electron temperature. Line pairs were found which lay conveniently close in one frame of the spectrometer allowing automatic on-line analysis without relying on reproducibility. Atomic physics models including opacity were developed for Ar II and Zn II in order to check the existence of a Boltzmann distribution of their excited states. These calculations showed that the observed levels were in fact close to thermodynamic equilibrium, in particular, if the resonance lines were optically thick. Electron temperature measurements yielded values between 14000 K and 21000 K. The gas temperature in the afterglow, where particles should have formed, was derived from the rotational and vibrational temperatures of C2 molecular bands. Ratios between Cu I line intensities yielded the electron temperatures. Both were found to be a few 1000 K. (© 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) [source]


    Affordable diagnostics,Changing the paradigm in India,,

    CYTOMETRY, Issue S1 2008
    Bala S. Manian
    Abstract A successful strategy for developing affordable diagnostics begins with a shift in viewpoint. Diagnostics is a tool for generating clinical information. Amassed experience in different parts of the globe has shown that this process of generating and utilizing clinical information is not only different among various countries but also different in microenvironments within the same country. The development of affordable diagnostics requires consideration not only of the component costs such as hardware and consumables but also other related costs that contribute to the generation and delivery of that information. It is important to recognize that these costs associated with public health in resource-poor settings cannot remain at the mercy of charitable contributions from western nations. Therefore, the challenge of technological innovation is to create solutions that are locally affordable and sustainable in the long run within the local macroeconomic constraints. The solutions should permit generation of local economic activity that will reinforce long-term economic sustainability. For this reason it is essential not only to analyze the diagnostic process but also to define a pathway by which local healthcare systems in recipient nations can be endowed with elements that empower them to acquire and practice up-to-date modern diagnostic skills. The objective of this paper is to provide a wider view of diagnostic cost components and to show how solutions developed and delivered locally have resulted in economically affordable as well as sustainable products. © 2008 Clinical Cytometry Society [source]


    Protocols for the diagnosis of quarantine pests,

    EPPO BULLETIN, Issue 3-4 2000

    EPPO member countries have recognized the need for a harmonized approach to detection and identification methods for quarantine pests. In 1998, EPPO started anew project to prepare diagnostic protocols for the quarantine pests of the EPPO region. The work is conducted by the Panel on Diagnostics, which is under the authority of the Working Party on Phytosanitary Regulations. The Panel consists of 10 experts in different fields. When necessary, expert groups on specific disciplines are called upon. The Panel agreed on a suitable common format for the protocols and a procedure for producing the best quality of diagnostic protocols. As there are about 325 quarantine pests for the region (listed in the EPPO A1 and A2 lists of quarantine pests and in the Annexes of EU Directive 77/93), it was necessary to decide upon a priority list of the organisms for which protocols should be developed first. At the moment, 52 protocols are at different stages of preparation. [source]


    Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, Issue 6 2007
    P. Valent
    Abstract Although a classification for mastocytosis and diagnostic criteria are available, there remains a need to define standards for the application of diagnostic tests, clinical evaluations, and treatment responses. To address these demands, leading experts discussed current issues and standards in mastocytosis in a Working Conference. The present article provides the resulting outcome with consensus statements, which focus on the appropriate application of clinical and laboratory tests, patient selection for interventional therapy, and the selection of appropriate drugs. In addition, treatment response criteria for the various clinical conditions, disease-specific symptoms, and specific pathologies are provided. Resulting recommendations and algorithms should greatly facilitate the management of patients with mastocytosis in clinical practice, selection of patients for therapies, and the conduct of clinical trials. [source]


    Atrial Fibrillation Burden During the Post-Implant Period After CRT Using Device-Based Diagnostics

    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Issue 8 2006
    BURKHARD HÜGL M.D.
    Aims: Cardiac resynchronization therapy (CRT) is increasingly used in congestive heart failure (CHF) patients (with cardiac dyssynchrony). In addition to delivering therapy, CRT devices offer a variety of diagnostic tools for continuous long-term monitoring of clinically relevant information (i.e., occurrence and duration of arrhythmia episodes). Methods and Results: Eighty-four patients with drug-refractory CHF in NYHA-class II,IV received a CRT device. The response to CRT was assessed by determining NYHA class at baseline and at 3 months follow-up. Atrial fibrillation (AF) burden (defined as time of AF per day) was continuously measured by the device. A significant gradual reduction of AF burden (from 9.88 ± 12.61 to 4.20 ± 9.24 [hours/day]) and number of patients experiencing AF episodes (from 26 to 13) were observed during CRT. Conclusions: (1) Diagnostic features for long-term monitoring of physiological variables provide useful information on the state and course of AF and may improve disease management. (2) AF burden reduces over time during the first 3 months after CRT implantation. [source]


    Evaluation of the Ortho-Clinical Diagnostics Vitros ECi Anti-HCV test: comparison with three other methods

    JOURNAL OF CLINICAL LABORATORY ANALYSIS, Issue 3 2007
    Jeannette M. Watterson
    Abstract After observing a high incidence of low positive hepatitis C virus (HCV) antibody screens by the Ortho-Clinical Vitros ECi test (Orthoclinical Diagnostics, Raritan, NJ), we compared results against those obtained using another chemiluminescent analyzer, as well as two U.S. Food and Drug Administration (FDA)-approved confirmatory methodologies. To ascertain the true anti-HCV status of samples deemed low-positive by the Ortho-Clinical Vitros ECi test, we tested samples using the ADVIA Centaur HCV screen test (Siemens Medical Solutions Diagnostics), the Chiron recombinant immunoblot assay (RIBA) test (Chiron Corp., Emeryville, CA), and the Roche COBAS Amplicor HCV qualitative test (Roche Diagnostics, Indianapolis, IN) in a series of studies. Of 94 specimens positive by Vitros ECi, 19% were observed to be negative by Centaur. A separate study of 91 samples with signal-to-cutoff (s/co) values less than 8.0 showed that all but one was negative for HCV ribonucleic acid (RNA). In comparison with RIBA, 100% (77) samples positive by the Vitros ECi test with s/co values less than 12.0 were negative or indeterminate by RIBA. A final study comparing all four methods side-by-side showed 63% disagreement by Centaur for Vitros ECi low-positive samples, 75% disagreement by RIBA, and 97% disagreement by polymerase chain reaction (PCR). In conclusion, the Ortho-Clinical Vitros ECi Anti-HCV test yields a high rate of false-positive results in the low s/co range in our patient population. J. Clin. Lab. Anal. 21:162,166, 2007. © 2007 Wiley-Liss, Inc. [source]


    ,-trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy

    JOURNAL OF CLINICAL LABORATORY ANALYSIS, Issue 4 2004
    Mami Kobata
    Abstract The relationship between serum levels of ,-trace protein (BTP) or serum creatinine (s-Cr) and the prognostic stages of type 2 diabetic nephropathy was determined. Serum samples from 174 patients with type 2 diabetes were obtained from Juntendo University Hospital, Tokyo, and Juntendo Urayasu Hospital, Chiba, Japan. They were classified into four groups according to the Report of the Ministry of Health and Welfare of Japan (1991, p 251,256) as follows: Stage I (normoalbuminuric stage), Stage II (microalbuminuric stage), Stage IIIA (macroalbuminuric stage without renal dysfunction), Stage IIIB (macroalbuminuric stage with renal dysfunction), and Stage IV (renal failure stage). Among these patients, 68 were Stage I, 29 Stage II, 32 Stage IIIA, 17 Stage IIIB, and 28 Stage IV. Levels of serum BTP were measured using the nephelometric assay on a BNA II analyzer (Dade Behring Diagnostics, Marburg, Germany). The mean levels of serum BTP in Stage IIIA were significantly higher than those in Stage I or II (P<0.00001, P<0.002, respectively). However, the mean levels of s-Cr in Stage IIIA were not significantly higher than that in Stage I or II. In conclusion, serum BTP was a good marker for the identification of early renal impairment in type 2 diabetes. J. Clin. Lab. Anal. 18:237,239, 2004. © 2004 Wiley-Liss, Inc. [source]


    Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays

    JOURNAL OF CLINICAL LABORATORY ANALYSIS, Issue 4 2001
    Amitava Dasgupta
    Abstract Troponin I is the regulatory subunit of troponin complex associated with the actin thin filament within muscle cells. Cardiac troponin I (cTnI) is a good marker for diagnosis of myocardial damage. Several immunoassays are available for determination of cTnI in serum. The Stratus cTnI fluorometric enzyme immunoassay (Dade International) uses alkaline phosphatase (ALP) substrate. The microparticle enzyme immunoassay (MEIA) for cTnI (Abbott Laboratories) also uses ALP conjugate. On the other hand, the chemiluminescent assay (CLIA) for cTnI (Bayer Diagnostics) does not use ALP. ALP activity may frequently be elevated in serum of patients being evaluated for suspected myocardial infarction. Therefore, we studied the potential interference of ALP in cTnI assays. Serum pools were prepared from patients, and various concentrations of ALP solution were added to different aliquots. The cTnI concentrations were measured by the Stratus, MEIA, and CLIA assays. We observed no interference of ALP in the MEIA and CLIA assay for cTnI. On the other hand, we observed significant positive interference of ALP when cTnI concentrations were measured using the Stratus. J. Clin. Lab. Anal. 15:175,177, 2001. © 2001 Wiley-Liss, Inc. [source]


    Negative interference of bilirubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK‐MB assay

    JOURNAL OF CLINICAL LABORATORY ANALYSIS, Issue 2 2001
    Amitava Dasgupta
    Abstract Troponin I is a sensitive and specific marker for the diagnosis of myocardial infarction. Several commercially available immunoassays measure the concentration of troponin I in serum. The microparticle enzyme immunoassay (MEIA) for troponin I (Abbott Laboratories, Abbott Park, IL) is widely used in clinical laboratories, including our hospital laboratory. We studied the effect of bilirubin and hemolysis on the MEIA for troponin I and compared our assay with a newly available chemiluminescent assay (CLIA) for troponin I (Bayer Diagnostics, Tarrytown, NY). We also measured CK‐MB concentration using the MEIA CK‐MB assay. One serum pool was prepared by combining several specimens of one patient with elevated troponin I and with a diagnosis of myocardial infarction. Other serum pools were prepared by combining sera with similar troponin I values. All serum pools showed normal bilirubin concentrations and had no hemolysis. Then we supplemented aliquots of serum pools with various concentrations of bilirubin (5.0, 10.0, 15.0, and 20.0 mg/dL). After supplementation, troponin I concentrations were measured again using the MEIA and CLIA. We observed a statistically significant decrease in troponin I concentration in the presence of bilirubin with the MEIA. For example, in serum pool 1, the troponin I concentration was 16.3 (bilirubin: 0.8 mg/dL). In the presence of 5.0, 10.0, 15.0 and 20.0 mg/dL of added bilirubin, the cardiac troponin I concentrations were 13.9, 13.4, 13.3 and 13.0 ng/ml respectively. We observed similar negative interference of bilirubin in troponin I measurement by the MEIA in other pools. The troponin I value decreased slightly (not statistically significant) in one pool and did not change in two other pools in the presence of bilirubin when we measured troponin I concentration using the CLIA. Interestingly, bilirubin did not interfere with the MEIA CK‐MB assay. Moderate hemolysis did not have any effect on the troponin I assay using either the MEIA or CLIA. However, gross hemolysis (hemoglobin > 40 mg/dL) interfered with both assays for troponin I. J. Clin. Lab. Anal. 15:76–80, 2001. © 2001 Wiley‐Liss, Inc. [source]


    Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin,

    JOURNAL OF MEDICAL VIROLOGY, Issue 5 2010
    Marion Levast
    Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real-time PCR techniques are available commercially and can detect more reliably low HBV DNA levels. The aim of this study was to determine the prevalence of occult hepatitis B virus infection using the COBAS Taqman assay (Roche Diagnostics, Meylan, France) in the serum and liver of HBsAg negative patients with chronic hepatitis C and to evaluate its clinical consequences on liver pathology and its impact on the response to treatment with peg-IFN, and Ribavirin. HBV DNA detection was assessed retrospectively on 140 sera and 113 liver biopsies of HCV positive/HBsAg negative patients before treatment. A 4.4% (5/113) prevalence of occult hepatitis B was recorded in liver samples and in none of the sera. Anti-HBc was not detected in one, three of whom were sustained virological responders to treatment, one was relapsed responder and one was non-responder. Furthermore, in this cohort composed of 12% anti-HBs negative/anti-HBc positive and 20% anti-HBs positive/anti-HBc positive patients, anti-HBc was not associated with pre-therapeutic viral load, ALT serum levels, and histological activity or fibrosis. Using a commercial real-time PCR assay, we observed a low prevalence of occult B hepatitis. This, just as anti-HBC status, had no clinical impact in a large cohort of hepatitis C patients. It therefore does not appear useful to screen for occult hepatitis B in these patients with this test before beginning HCV treatment. J. Med. Virol. 82: 000,000, 2010. © 2010 Wiley-Liss, Inc. J. Med. Virol. 82: 747,754, 2010. © 2010 Wiley-Liss, Inc. [source]


    Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital

    JOURNAL OF MEDICAL VIROLOGY, Issue 3 2009
    Azwidowi Lukhwareni
    Abstract This retrospective study investigated the prevalence of hepatitis B virus (HBV) in 192 stored sera from human immunodeficiency virus (HIV) positive South African patients initiating antiretroviral therapy (ART), and explored the implications of HBV,HIV co-infection on laboratory diagnosis of HBV. HBV serology (HBsAg, anti-HBs and anti-HBc) and nested HBV PCR assays targeting the HBV polymerase gene were performed, with HBV DNA positive samples being quantified with Cobas Taqman HBV test 48 assay (Roche Diagnostics). The study found that 63% (121/192) of patients had past or present HBV infection, and 40.6% (78/192) had detectable HBV DNA. Also, 22.9% (44/192) of patients were HBsAg positive and HBV DNA positive, while 23% (34/148) of HBsAG negatives had occult HBV infections. Of the 78 HBV DNA positive samples, 62.8% had viral loads ranging from 102 to ,108 IU/ml, and 37.2% had HBV viral loads <200 IU/ml. There was a statistically significant positive association between HBsAg-positivity and high viral loads, with 27% (12/44) of HBsAg positives having HBV viral loads between 104 and ,108 IU/ml, compared to only 5.9% (2/34) of HBsAg negatives (relative risk: 4.64; 95% confidence interval: 1.11, 19.35; chi-square P -value,=,0.015). The study shows that the majority of HIV/AIDS patients initiating ART have either acute or chronic HBV infections, and further confirms that HIV remains a risk factor for occult HBV infections in South African patients as previously shown. The findings strongly support HBV screening in all HIV-positive patients initiating ART in South Africa, considering that current ART regimens include drugs with anti-HBV activity (e.g., lamivudine). J. Med. Virol. 81:406,412, 2009. © 2009 Wiley-Liss, Inc. [source]


    Hepatitis B virus markers in anti-HBc only positive individuals,

    JOURNAL OF MEDICAL VIROLOGY, Issue 3 2001
    Bernard Weber
    Abstract Isolated reactivity to hepatitis B virus (HBV) core antigen (anti-HBc) is observed relatively frequently in immunocompromised individuals, intravenous drug abusers (IVDA), and in the presence of HCV infection. The reason for the lack of HBsAg is not clear. The aim of the present study was to investigate which factors (genetic variability of S gene, low-level HBsAg, and immune complexes may be responsible for the failure of HBsAg detection with commercial HBsAg screening assays. Dilution series of two recombinant HBsAg escape mutants and dilutions of serum samples from chronic HBV carriers with multiple insertions in the a determinant and different HBsAg subtypes were tested with a highly sensitive assay that detects wild-type HBsAg (Elecsys HBsAg, Roche Diagnostics, Penzberg, Germany) and two assays that detect HBV wild-type and escape mutants (Murex HBsAg Version 3, Murex and Enzygnost HBsAg 5.0, Dade Behring, Marburg, Germany). Elecsys HBsAg showed in comparison to Murex HBsAg Version 3 and Enzygnost HBsAg 5.0 a reduced sensitivity for escape mutant detection. On the other hand, the best performance for HBsAg subtype detection was obtained with Elecsys HBsAg. In the second part of the study, a selected panel of isolated anti-HBc reactive (n,=,104) serum samples (AxSYM Core) was submitted to testing by Elecsys HBsAg, Murex HBsAg Version 3, Enzygnost HBsAg 5.0, and HBsAg detection after immune complex dissociation (ICD) and anti-HBs determination with two different assays (AxSYM Ausab and Elecsys Anti-HBs). To assess the specificity of anti-HBc test results, all the samples were tested by a second anti-HBc assay (Elecsys Anti-HBc). Quantitative HBV DNA detection was undertaken with a commercially available HBV PCR assay (Amplicor HBV Monitor). HCV infection was present in 65.4% of anti-HBc only reactive individuals. Five AxSYM Core positive samples were negative by Elecsys Anti-HBc. Overall, 15 (14.4%) AxSYM Ausab negative samples gave positive results with Elecsys Anti-HBs (median value: 21 IU/ml). No low-level HBsAg carrier was detected among the isolated anti-HBc reactive individuals with Elecsys HBsAg. There was no evidence for the presence of immune complexes. Only one sample was repeatedly reactive by the Murex HBsAg, suggesting that the a mutant form of HBsAg was responsible for the isolated anti-HBc reactivity, however neutralisation assay was not interpretable and HBV DNA PCR was negative. Fifteen (14.4%) anti-HBc only positive individuals were HBV DNA carriers with concentrations ranging from 800 to more than >4,000,000 copies of viral DNA/ml. In conclusion, the most probable explanations for isolated anti-HBc reactivity in our study group are a possible interference of HBsAg synthesis by HCV infection (65.4%) and divergence of results of anti-HBs assays (14.4%). There is no evidence for the presence of low-level HBsAg carriers and immune complexes. HBsAg mutants cannot be excluded definitively by the test strategy used in the present evaluation. J. Med. Virol. 64:312,319, 2001. © 2001 Wiley-Liss, Inc. [source]


    AFLP Analysis of Trichoderma spp. from India Compared with Sequence and Morphological-based Diagnostics

    JOURNAL OF PHYTOPATHOLOGY, Issue 7-8 2005
    H. K. Buhariwalla
    Abstract Trichoderma species offer considerable potential for controlling aflatoxin contamination in groundnut and other crops. Initial classification of 48 Trichoderma isolates, derived from four different groundnut cultivation sites in India was based on alignment of 28S rDNA sequences to GenBank sequences of ex-type strains. This was found to be substantially more reliable than our routine morphological characterization, but did not provide a comprehensive diagnostic solution, as unique single nucleotide polymorphism (SNP) haplotypes could not be identified for all species. However, all the Trichoderma isolates could be readily distinguished by amplified fragment length polymorphism (AFLP) analysis, based on six primer pair combinations, which generated 234 polymorphic bands. In addition, individual AFLP bands were identified which differentiate closely related species. Similarly, AFLP bands were identified that correlated with different types of antagonism to Aspergillus flavus. The implications of these results for the development of simple polymerase chain reaction (PCR)-based diagnostic assays for antagonistic isolates of Trichoderma is discussed. [source]


    Comparison of measurements of 18 analytes in canine and feline blood samples using the in-practice Falcor 350 and the reference KoneLab 30i analysers

    JOURNAL OF SMALL ANIMAL PRACTICE, Issue 10 2008
    K. Papasouliotis
    Objectives: Falcor 350 (A. Menarini Diagnostics) is a wet-reagent biochemistry analyser that is available for in-house use. The aim of this study was to compare the results produced by this analyser with those obtained by a wet-reagent analyser (KoneLab 30i; Thermo Clinical Labsystems) that served as the reference instrument. Methods: Blood samples from 120 clinical cases (60 dogs and 60 cats) were analysed for 18 analytes (urea, creatinine, total proteins, albumin, creatine kinase, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bilirubin, amylase, lipase, glucose, triacylglycerol, cholesterol, total calcium, phosphate, sodium and potassium) using both the reference and Falcor instruments. Results: Good to excellent correlations (rs value) (canine/feline) were identified for urea (0·87/0·86), creatinine (0·96/0·99), total proteins (0·91/0·95), albumin (0·96/0·93), creatine kinase (0·98/0·99), aspartate aminotransferase (0·95/0·98), alanine aminotransferase (0·99/0·99), alkaline phosphatase (0·99/0·98), total bilirubin in dogs (0·88), amylase (0·99/0·87), lipase in dogs (0·88), glucose (0·97/0·98), triacylglycerol (0·93/0·97), cholesterol (0·99/0·99), total calcium (0·88/0·89), phosphate (0·94/0·97) and potassium (0·96/0·97). The correlations for sodium (0·41/0·61), total bilirubin in cats (0·78) and lipase in cats (0·25) were considered unacceptable. Clinical Significance: For 13 of the 18 analytes (creatinine, total proteins, albumin, creatine kinase, aspartate aminotransferase, alanine aminotransferase, amylase, glucose, cholesterol, triacylglycerol, phosphate, potassium and urea) in both canine and feline samples, the two instruments produce values that are closely related to each other (excellent correlation) and are sufficiently similar to allow them to be used interchangeably without the need for additional correction factor computations (good agreement). Because of differences in the methodologies, the Falcor results for alkaline phosphatase, total calcium, sodium, lipase and total bilirubin cannot be used interchangeably with those generated by the KoneLab and should be interpreted using reference intervals established from the Falcor analyser. [source]


    Diagnostics for multivariate imputations

    JOURNAL OF THE ROYAL STATISTICAL SOCIETY: SERIES C (APPLIED STATISTICS), Issue 3 2008
    Kobi Abayomi
    Summary., We consider three sorts of diagnostics for random imputations: displays of the completed data, which are intended to reveal unusual patterns that might suggest problems with the imputations, comparisons of the distributions of observed and imputed data values and checks of the fit of observed data to the model that is used to create the imputations. We formulate these methods in terms of sequential regression multivariate imputation, which is an iterative procedure in which the missing values of each variable are randomly imputed conditionally on all the other variables in the completed data matrix. We also consider a recalibration procedure for sequential regression imputations. We apply these methods to the 2002 environmental sustainability index, which is a linear aggregation of 64 environmental variables on 142 countries. [source]


    The multivariate Gaussian tail model: an application to oceanographic data

    JOURNAL OF THE ROYAL STATISTICAL SOCIETY: SERIES C (APPLIED STATISTICS), Issue 1 2000
    P. Bortot
    Optimal design of sea-walls requires the extreme value analysis of a variety of oceanographic data. Asymptotic arguments suggest the use of multivariate extreme value models, but empirical studies based on data from several UK locations have revealed an inadequacy of this class for modelling the types of dependence that are often encountered in such data. This paper develops a specific model based on the marginal transformation of the tail of a multivariate Gaussian distribution and examines its utility in overcoming the limitations that are encountered with the current methodology. Diagnostics for the model are developed and the robustness of the model is demonstrated through a simulation study. Our analysis focuses on extreme sea-levels at Newlyn, a port in south-west England, for which previous studies had given conflicting estimates of the probability of flooding. The novel diagnostics suggest that this discrepancy may be due to the weak dependence at extreme levels between wave periods and both wave heights and still water levels. The multivariate Gaussian tail model is shown to resolve the conflict and to offer a convincing description of the extremal sea-state process at Newlyn. [source]


    Editorial: Diarrhea, Diet, and Diagnostics

    JOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 1 2001
    Dipl ACVIM, M.D. Willard DVM
    No abstract is available for this article. [source]


    Multifunctional Magnetoplasmonic Nanoparticle Assemblies for Cancer Therapy and Diagnostics (Theranostics),

    MACROMOLECULAR RAPID COMMUNICATIONS, Issue 2 2010
    Wei Chen
    Abstract In this work, we describe the preparation and biomedical functionalities of complex nanoparticle assemblies with magnetoplasmonic properties suitable for simultaneous cancer therapy and diagnostics (theranostics). Most commonly magnetoplasmonic nanostructures are made by careful adaptation of metal reduction protocols which is both tedious and restrictive. Here we apply the strategy of nanoscale assemblies to prepare such systems from individual building blocks. The prepared superstructures are based on magnetic Fe3O4 nanoparticles encapsulated in silica shell representing the magnetic module. The cores are surrounded in a corona-like fashion by gold nanoparticles representing the plasmonic module. As additional functionality they were also coated by poly(ethyleneglycol) chains as a cloaking agent to extend the blood circulation time. The preparation is exceptionally simple and allows one to vary the contribution of each function. Both modules can carry drugs and, in this study, they were loaded with the potential anticancer drug curcumin. A comprehensive set of microscopy, spectroscopy and biochemical methods were applied to characterize both imaging and therapeutic function of the nanoparticle assemblies against leukemia HL-60 cells. High contrast magnetic resonance images and high apoptosis rates demonstrate the success of assembly approach for the preparation of magnetoplasmonic nanoparticles. This technology allows one to easily "dial in" the functionalities in the clinical setting for personalized theranostic regiments. [source]


    Comparative evaluation of Candi Select test and conventional methods for identification of Candida albicans in routine clinical isolates

    MYCOSES, Issue 3-4 2002
    S. Foongladda
    Candida albicans; Identifizierung; Candi Select- Test; Bewertung. Summary. The Candi Select test (Sanofi Diagnostics, Pasteur, Marnes-La-Coquette, France) is a new yeast-selective medium for the identification of Candida albicans in the clinical laboratory. The performance of this test was compared with the conventional methods of chlamydospore formation, germ tube formation and carbohydrate fermentation. Four hundred and twenty clinical yeast isolates from 412 fresh clinical specimens, including 283 C. albicans, 59 C. tropicalis, 39 Trichosporon spp., 19 C. glabrata, 11 Cryptococcus neoformans and 9 other yeasts, were evaluated. Colonies of C. albicans produced a blue-green colour on the Candi Select media which could be distinguished from the other yeasts with the naked eye within 24,48 h. The sensitivity and specificity of the Candi Select test for the identification of C. albicans were 99.65% and 97.08%, respectively. The blue-green colonies of C. albicans were easy to identify and recognize in mixed cultures and did not need detailed microscopic examination. Zusammenfassung., Der Candi Select-Test (Sanofi Diagnostics Pasteur, Marnes-La-Coquette, Frankreich) ist ein neuer selektiver Nährboden für die Identifizierung von Candida albicans im klinischen Labor. Die neue Methode wurde mit den konventionellen Methoden der Chlamydosporenbildung, der Keimschlauchbildung und der Kohlenhydrat-Gärung verglichen. Vierhundertzwanzig Hefeisolate, nämlich 283 C. albicans, 59 Candida tropicalis, 39 Trichosporon spp., 19 Candida glabrata, 11 Cryptococcus neoformans und 9 andere Hefen, isoliert aus 412 frischen klinischen Untersuchungsproben, wurden mit allen Methoden untersucht. Mit blossem Auge erkennbar, unterschieden sich innerhalb von 24,48 Stunden die blau-grünen Farbkolonien von C. albicans von allen anderen Hefen auf dem Candi Select Nährboden. Sensitivität und Spezifizität des Candi Select Tests für die Identifizierung von C. albicans betrugen 99.65% und 97.08%. Die blau-grünen Farbkolonien von C. albicans waren in den Mischkulturen leicht zu identifizieren, eine mikroskopische Untersuchung erübrigt sich daher. [source]


    Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia

    AMERICAN JOURNAL OF HEMATOLOGY, Issue 3 2008
    Maren Chan
    Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy. Limited data are available regarding repeat HIT antibody testing after an initial negative test. We conducted a retrospective study to determine the utility of repeat testing. Heparin antibodies were detected using the GTI-PF4 enzyme-linked immunoabsorbent assay, ELISA (GTI Diagnostics, Waukesha, WI). Patients (n = 137) were assigned to one of three groups based upon the initial negative test optical density (OD) range of low = 0,0.132, medium = 0.133,0.267, and high = 0.268,0.399. A pretest clinical score was retrospectively determined using the "4T's" (Thrombocytopenia, Timing of platelet fall, Thrombosis, and the absence of oTher causes of thrombocytopenia). A subsequent positive ELISA was found in 16% (22/137) of patients who underwent repeat testing. Most of these patients had a low pretest clinical score (62%). Four patients had an interval change in the pretest score between the initial negative and subsequent positive tests. Only these four patients developed HIT with thrombosis (HITT). Eighty percent of patients with a high initial negative test OD value had a positive ELISA on repeat testing; however, the initial negative test OD value could not predict whether a patient developed HITT. In contrast, an increase in the pretest clinical probability between initial and repeat testing better predicted HITT. Consecutive repeat ELISA testing for heparin antibodies may be warranted in patients with an increase in their pretest clinical score after an initial negative test as an adjunct to confirm the diagnosis of HIT. Am. J. Hematol., 2008. © 2007 Wiley-Liss, Inc. [source]


    Probe Diagnostics of Expanding Plasmas at Low Gas Pressure

    PLASMA PROCESSES AND POLYMERS, Issue 2 2006
    Mariya Dimitrova
    Abstract Summary: Results from tandem-type probe diagnostics of a plasma source based on an inductive discharge are presented in this study. The driver region is in the classical form of a cylindrically shaped inductive discharge, with a coil positioned over a gas discharge tube, whereas a bigger metal chamber provides volume for plasma expansion. Low pressure argon discharges were studied. The axial profiles of the plasma parameters were measured in the discharge in the metal chamber. The results obtained show that decreasing electron temperature and plasma density with increasing distance from the driver characterizes the behavior of the expanding plasmas. Moreover, two regions with different rates of variation of the plasma parameters complete the plasma expansion volume: a faster drop close to the driver and slow axial changes away from it. The gas pressure and power applied for the discharge maintenance were the external parameters varied. Axial profiles of the electron concentration in the plasma expansion region of an inductive discharge. [source]


    Field Trial of Biosparging with Oxygen for Bioremediation of Volatile Organic Compounds

    REMEDIATION, Issue 4 2001
    Kenneth L. Sperry
    Xpert Design & Diagnostics, LLC (XDD), & Conestoga-Rovers and Associates (CRA) conducted a biosparging field trial at a Superfund site in New Jersey. The biosparging field trial proved that biosparging with oxygen was very effective in promoting the biological destruction of benzene. The approximately 265-day period of oxygen injection successfully reduced benzene concentrations by several orders of magnitude, or even to non-detect values, at least 40 feet from the point of injection. Through co-precipitation of arsenic with oxidized iron, biosparging also effectively reduced total concentrations of arsenic and iron in groundwater. Based on the results of the biosparging field trial, the final remedy for the site has been amended to include the use of biosparging technology as an alternative to groundwater pumping and aboveground treatment in select locations. © 2001 John Wiley & Sons,Inc. [source]


    Diagnostics and staging procedures in non-small cell lung cancer , is less more?

    THE CLINICAL RESPIRATORY JOURNAL, Issue 2 2008
    David Felix Heigener
    Abstract Introduction:, Non-small cell lung cancer (NSCLC) is a common cancer with approximately 85% of patients dying of the disease. The only chance for cure is in the early stages, when surgery or definite chemoradiotherapy can be performed. Diagnosis and staging of lung cancer can sometimes be difficult, particularly because the intrathoracic structures are not easy to reach. Objective:, This review discusses the diagnosis and staging of lung cancer. Results:, When performing lung cancer diagnostics, both invasive and noninvasive procedures, such as computed tomogram of the chest, bronchoscopy and abdominal ultrasound, are mandatory. Suspected mediastinal involvement should be differentiated: bulky disease, contralateral or high mediastinal nodes need further clarification by endoscopic ultrasound, endobronchial ultrasound or mediastinoscopy. In opposition to current guidelines, in all other cases, surgery should be performed. Positron emission tomography will gain even more importance when becoming widely accessible and might replace other imaging techniques in the future. In case of advanced disease, staging should be limited to those examinations with impact on symptom control. Conclusion:, The diagnosis and staging of lung cancer should involve both invasive and noninvasive diagnostic procedures. In the case of advanced disease, staging should be limited to those examinations with impact on symptom control, whereas early stages call for rapid and thorough diagnosis. Please cite this paper as: Heigener DF, Diemel K-D, Reck M and Gatzemeier U. Diagnostics and staging procedures in non-small cell lung cancer , is less more? The Clinical Respiratory Journal 2008; 2: 67,73. [source]


    Variability of the North Atlantic eddy-driven jet stream

    THE QUARTERLY JOURNAL OF THE ROYAL METEOROLOGICAL SOCIETY, Issue 649 2010
    Tim Woollings
    Abstract Much of the atmospheric variability in the North Atlantic sector is associated with variations in the eddy-driven component of the zonal flow. Here we present a simple method to specifically diagnose this component of the flow using the low-level wind field (925,700 hpa ). We focus on the North Atlantic winter season in the ERA-40 reanalysis. Diagnostics of the latitude and speed of the eddy-driven jet stream are compared with conventional diagnostics of the North Atlantic Oscillation (NAO) and the East Atlantic (EA) pattern. This shows that the NAO and the EA both describe combined changes in the latitude and speed of the jet stream. It is therefore necessary, but not always sufficient, to consider both the NAO and the EA in identifying changes in the jet stream. The jet stream analysis suggests that there are three preferred latitudinal positions of the North Atlantic eddy-driven jet stream in winter. This result is in very good agreement with the application of a statistical mixture model to the two-dimensional state space defined by the NAO and the EA. These results are consistent with several other studies which identify four European/Atlantic regimes, comprising three jet stream patterns plus European blocking events. Copyright © 2010 Royal Meteorological Society [source]


    An objective definition of the Indian summer monsoon season and a new perspective on the ENSO,monsoon relationship

    THE QUARTERLY JOURNAL OF THE ROYAL METEOROLOGICAL SOCIETY, Issue 624 2007
    Prince K. Xavier
    The concept of an interannually varying Indian summer monsoon season is introduced here, considering that the duration of the primary driving of the Indian monsoon,the large-scale meridional gradient of the deep tropospheric heat source,may vary from one year to another. Onset (withdrawal) is defined as the day when the tropospheric heat source shifts from south to north (north to south). This physical principle leads to a new thermodynamic index of the seasonal mean monsoon. While the traditional measure of seasonal rainfall, averaged from 1 June to 30 September, indicates a breakdown of the ENSO,monsoon relationship in recent decades, it is argued that this breakdown is partly due to the inappropriate definition of a fixed monsoon season. With a new physically based definition of the seasonal mean, the ENSO,monsoon relationship has remained steady over the decades. El Niño (La Niña) events contract (expand) the season, and thus decrease (increase) the seasonal mean monsoon by setting up persistent negative (positive) tropospheric temperature (TT) anomalies over the southern Eurasian region. Thus, we propose a new pathway, whereby the Indian summer monsoon could be influenced by remote climatic phenomena via modification of TT over Eurasia. Diagnostics of the onset and withdrawal processes suggest that onset delay is due to the enhanced adiabatic subsidence that inhibits vertical mixing of sensible heating from warm landmass during the pre-monsoon months. On the other hand, the major factor that determines whether the withdrawal is early or late is the horizontal advective cooling. Most of the late (early) onsets and early (late) withdrawals are associated with El Niño (La Niña). This link between the ENSO and the monsoon is realized through vertical and horizontal advections associated with the stationary waves in the upper troposphere set up by the tropical ENSO heating. Copyright © 2007 Royal Meteorological Society [source]


    Response of the Asian summer monsoon to changes in El Niño properties

    THE QUARTERLY JOURNAL OF THE ROYAL METEOROLOGICAL SOCIETY, Issue 607 2005
    H. Annamalai
    Abstract Diagnostics from observed precipitation and National Centers for Environmental Prediction,National Center for Atmospheric Research re-analysis products reveal that after the 1976,77 climate shift in the Pacific there was a dramatic change in the response of the Indian summer monsoon (ISM) to El Niño, particularly during the months of July and August. Based on 1950,75 (PRE76) and 1977,2001 (POST76) El Niño composites: the western North Pacific monsoon (WNPM) was stronger than normal in both periods; the ISM was weaker than normal during the entire monsoon season in PRE76, but in POST76 was weaker only during the onset and withdrawal phases. In terms of observed sea surface temperature (SST) during July,August, the major differences between the two periods are the presence of cold SST anomalies over the Indo,Pacific warm pool and the intensity of warm SST anomalies in the central Pacific in POST76. The effect of these differences on the ISM is investigated in a suite of experiments with an Atmospheric General Circulation Model (AGCM) that has a realistic monsoon precipitation climatology. Separate ten-member ensemble simulations with the AGCM were conducted for PRE76 and POST76 El Niño events with SST anomalies inserted as follows: (i) tropical Indo,Pacific (TIP), (ii) tropical Pacific only (TPO), and (iii) tropical Indian Ocean only (TIO). Qualitatively, TPO solutions reproduce the observed differences in the monsoon response in both periods. Specifically, during July,August of POST76 the cold SST anomalies in conjunction with remote subsidence suppress precipitation (3,5 mm day,1) over the maritime continent and equatorial central Indian Ocean. Inclusion of Indian Ocean SST anomalies in the TIP runs further suppresses precipitation over the entire equatorial Indian Ocean. The low-level anticyclonic circulation anomalies that develop as a Rossby-wave response to these convective anomalies increase the south-westerlies over the northern Indian Ocean, and favour a stronger ISM and WNPM. During PRE76 the non-occurrence of cold SST anomalies over the Indo,Pacific warm pool reinforces El Niño's suppression on the ISM. In contrast, TIO solutions show a reduced ISM during July,August of POST76; the solutions, however, show a significant effect on the WNPM during both PRE76 and POST76 periods. It is argued that SSTs over the entire tropical Indo,Pacific region need to be considered to understand the El Niño Southern Oscillation,monsoon linkage, and to make predictions of rainfall over India and the western North Pacific. Copyright © 2005 Royal Meteorological Society [source]